Oyin Alao, MPH

Oyin Alao is a Biomedical Research Manager at Reboot Rx, where she analyzes clinical studies, leads expert discussions, and evaluates emerging drug discoveries to support data-driven cancer treatment strategies. Since joining Reboot Rx, she has played an important role in strengthening the organization’s evidence synthesis efforts.

Oyin has co-authored multiple research publications, including work expanding the clinical and genomic landscape of metastatic breast cancer and several pediatric oncology studies. Her background reflects a commitment to research that directly informs patient care.

Before joining Reboot Rx, Oyin worked at the Broad Institute of MIT and Harvard on the Count Me In initiative and contributed to pediatric oncology research at Children’s Healthcare of Atlanta. She holds a Master of Public Health in Health Policy and Management from Emory University and a Bachelor of Science in Biochemistry from Northeastern University.